Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8921838 | 1.00 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL11501635 | 1.00 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL8558475 | 1.00 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL1415394 | 0.97 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL386067 | 0.97 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL11554992 | 0.94 | — | — | |
| SCHEMBL3789483 | 0.94 | — | — | |
| SCHEMBL8638311 | 0.94 | — | — | |
| SCHEMBL11501880 | 0.94 | — | — | |
| SCHEMBL6840832 | 0.91 | ALDH1A1 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 823 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974896-A | Novel pyrimidopyridine compounds, pharmaceutical compositions thereof and uses thereof | 广东东阳光药业有限公司 | 2023-04-18 | — | — | CN | claimed |
| EP-3668880-B1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-10-06 | — | — | EP | claimed |
| EP-3722278-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2020-10-14 | — | — | EP | claimed |
| US-20200216467-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2020-07-09 | — | — | US | claimed |
| EP-3668880-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | Idorsia Pharmaceuticals Ltd (CH) | 2020-06-24 | — | — | EP | claimed |
| CN-111225899-A | Polymerizable polar compound, liquid crystal composition, and liquid crystal display element | 捷恩智株式会社 | 2020-06-02 | — | — | CN | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| WO-2019034725-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2019-02-21 | — | — | WO | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8791303-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2014-07-29 | — | — | US | claimed |
| EP-0298919-A2 | 4-amino-substituted 1,2-dihydroxynaphthalene derivatives | CIBA-GEIGY AG (CH) | 1989-01-11 | — | — | EP | claimed |
| EP-0274023-A1 | Saccharine salt of substituted amines | BAYER AG (DE) | 1988-07-13 | — | — | EP | claimed |
| EP-0254150-A1 | Decahydronaphthyl-2-alkyl amines | BAYER AG (DE) | 1988-01-27 | — | — | EP | claimed |
| EP-0243449-A1 | CYCLIC HYDROCARBONS WITH AN AMINOALKYL SIDECHAIN | THE UPJOHN COMPANY (US) | 1987-11-04 | — | — | EP | claimed |
| WO-1987002367-A2 | CYCLIC HYDROCARBONS WITH AN AMINOALKYL SIDECHAIN | THE UPJOHN COMPANY (US) | 1987-04-23 | — | — | WO | claimed |
| US-RE31342-E | STABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1983-08-09 | — | — | US | claimed |
| US-RE31343-E | STABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1983-08-09 | — | — | US | claimed |
| US-4112099-A | FIBRINOLYTICS, THROMBOLYTICS, ANTIPHLOGISTICS, ANALGESICS | CIBA-GEIGY CORPORATION (US) | 1978-09-05 | — | — | US | claimed |
| US-4076822-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1978-02-28 | — | — | US | claimed |
| US-3980657-A | FIBRINOLYTICS, THROMBOLYTICS, ANTIPHLOGISTICS, ANALGESICS | CIBA-GEIGY CORPORATION (US) | 1976-09-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216467-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDO2, IDO1, TDO2 | ALDH1A1 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.